Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug
Mesoblast Limited MESO recently announced that the FDA has granted a Rare Pediatric Disease (RPD) designation to its allogeneic cell therapy, Revascor (rexlemestrocel-L), for treating children with co...